ozempic novo nordisk - Search News

weight loss, Ozempic and Dr. Christopher

Is Ozempic safe for weight loss? What doctors want you to know about blockbuster drug

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 drugs, and whether they're safe.

Newsweek on MSN · 3d

Ozempic and Blindness: What We Know About Weight Loss Side Effects

Symptoms of NAION can include blurred vision, peripheral vision loss, dark spots in vision, and changes in color perception. Though the exact mechanism is not fully understood, researchers hypothesize that rapid blood sugar reduction caused by semaglutide may damage blood vessels in the eyes, contributing to this condition.

FOX News on MSN · 17h

Weight-loss, diabetes drugs linked to vision problems in small study

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Straight Arrow News on MSN · 1d

Vision loss possibly linked to Ozempic, weight loss injections: Study

Millions of Americans use GLP-1 injections like Ozempic to lose weight. A study is questioning whether they can cause vision loss.

Ozempic, alcohol

Ozempic shows some promise for alcohol use disorder

Novo Nordisk’s blockbuster GLP-1 diabetes drug Ozempic led to improvements in some measures of alcohol use disorder in a small trial, researchers reported on Wednesday.

Newsweek on MSN · 1d

Ozempic Trial Shows Drug Turns People Off Alcohol

Results showed that people craved and drank less alcohol when on the drug, according to the findings of a recent study.

devdiscourse · 2d

Ozempic's Potential in Combating Alcohol Use Disorder Uncovered

In a small trial, Novo Nordisk's diabetes drug Ozempic showed promise in reducing alcohol consumption and cravings in individuals with alcohol use disorder. Participants treated with Ozempic displayed a significant reduction in alcohol intake compared to those given a placebo.

1don MSN

Why Novo Nordisk Stock Keeps Going Down

Novo Nordisk ( NVO -1.22%) stock is in a funk. Shares of the GLP-1 diet drug manufacturer have been sliding all week long, ...

22h

Does Medicare Cover Ozempic?

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

5h

Bandits’ New Demand in Brazil: Hand Over the Ozempic!

Criminals are targeting pharmacies and stealing weight-loss medication in a country with body image insecurities and where ...

20hon MSN

Novo Nordisk stock is having a rough week after that Hims & Hers Super Bowl ad

Novo Nordisk (NVO) stock took a hit this week, after a Super Bowl ad highlighted a growing challenge to the company’s ...

1d

Novo Suffers Loss in Lawsuit Against Pharmacy’s Copycat Ozempic

Novo Nordisk A/S failed to convince a federal judge that a pharmacy in Florida making compounded versions of its diabetes and ...

9d

Novo Nordisk Annual Sales Jump on Higher Demand for Obesity Drugs

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...

9don MSN

Novo Nordisk Stock Rises as Q4 Wegovy Sales More Than Double

Novo Nordisk's U.S.-listed shares rose 5% in intraday trading after the Ozempic and Wegovy maker's better-than-estimated ...

3don MSN

Ozempic, Wegovy maker calls out Hims & Hers Super Bowl ad: ‘Check before you inject’

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results